FUNDC1 and metabolic dysfunction-associated steatotic liver disease: In summary, our findings indicate that genetic ablation of CK2α restores FUNDC1 mitophagy, and alleviates mitochondrial injury and ferroptosis to protect against HFD‐induced hepatic metabolic injury and MASLD progression (Figure 8G).